Chronic Traumatic Encephalopathy : The Neuropathological Legacy of Traumatic Brain Injury
暂无分享,去创建一个
[1] Qijun Wu,et al. Circulating adiponectin, leptin and adiponectin–leptin ratio and endometrial cancer risk: Evidence from a meta‐analysis of epidemiologic studies , 2015, International journal of cancer.
[2] C. Hutter,et al. Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants , 2015 .
[3] Graham A. Colditz,et al. Prevalence of Overweight and Obesity in the United States, 2007-2012. , 2015, JAMA internal medicine.
[4] S. Upala,et al. Bariatric surgery and risk of postoperative endometrial cancer: a systematic review and meta-analysis. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[5] M. Kew. Obesity as a cause of hepatocellular carcinoma. , 2015, Annals of hepatology.
[6] Alisha M. Mendonsa,et al. Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells , 2015, PloS one.
[7] Sean M. Kearney,et al. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. , 2015, Cancer Research.
[8] G. Hu,et al. New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.
[9] O. Mandelboim,et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance , 2015, Nature Immunology.
[10] M. Rigla,et al. Does bariatric surgery reduce cancer risk? A review of the literature. , 2015, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.
[11] Qinghua Sun,et al. Macrophage recruitment in obese adipose tissue , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[12] J. Gimble,et al. Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells , 2015, Stem cells.
[13] W. Shi,et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue–resident regulatory T cells , 2015, Nature Immunology.
[14] C. Hudis,et al. Obesity and cancer: local and systemic mechanisms. , 2015, Annual review of medicine.
[15] Shuming Sun,et al. IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury. , 2015, Journal of the American Society of Nephrology : JASN.
[16] C. Giordano,et al. The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression , 2014, Front. Oncol..
[17] P. Schumacker,et al. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.
[18] D. Gozal,et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.
[19] P. Scherer,et al. Hyperglycemia as a Risk Factor for Cancer Progression , 2014, Diabetes & metabolism journal.
[20] K. Bhaskaran,et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.
[21] A. Courcoulas,et al. Bariatric surgery for obesity and metabolic conditions in adults , 2014, BMJ : British Medical Journal.
[22] A. Brenner,et al. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. , 2014, Cancer research.
[23] D. Cipolletta. Adipose tissue‐resident regulatory T cells: phenotypic specialization, functions and therapeutic potential , 2014, Immunology.
[24] J. O’Sullivan,et al. Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive , 2014, British Journal of Cancer.
[25] Jeffrey W Pollard,et al. Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.
[26] J. Olefsky,et al. Macrophages, immunity, and metabolic disease. , 2014, Immunity.
[27] J. Lara,et al. The Effects of Bariatric Surgery on Colorectal Cancer Risk: Systematic Review and Meta-analysis , 2014, Obesity Surgery.
[28] M. Singer,et al. Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[29] X. Shu,et al. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women , 2014, Breast Cancer Research and Treatment.
[30] Z. Yao,et al. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling , 2014, Oncotarget.
[31] Z. Derdák,et al. Obesity-associated mechanisms of hepatocarcinogenesis. , 2014, Metabolism: clinical and experimental.
[32] K. Flegal,et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.
[33] I. Fonseca,et al. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression , 2014, BMC Cancer.
[34] Liang Song,et al. Interleukin-6 in inflammatory and malignant diseases of the pancreas. , 2014, Seminars in immunology.
[35] R. Gonzalez-Perez,et al. Leptin–cytokine crosstalk in breast cancer , 2014, Molecular and Cellular Endocrinology.
[36] J. Reynolds,et al. The role of obesity in gastrointestinal cancer: evidence and opinion , 2014, Therapeutic advances in gastroenterology.
[37] K. Clément,et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. , 2013, The American journal of clinical nutrition.
[38] R. Locksley,et al. Cutting Edge: IL-25 Elicits Innate Lymphoid Type 2 and Type II NKT Cells That Regulate Obesity in Mice , 2013, The Journal of Immunology.
[39] Jeff S. Jasper,et al. 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology , 2013, Science.
[40] L. Girard,et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. , 2013, Cell reports.
[41] A. Diehl,et al. NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.
[42] G. Mills,et al. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women , 2013, Breast Cancer Research and Treatment.
[43] E. Lengyel,et al. Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.
[44] D. Silverman,et al. Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. , 2013, The American journal of clinical nutrition.
[45] K. Ladell,et al. Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells , 2013, Mucosal Immunology.
[46] E. Rosen,et al. Interferon Regulatory Factor 4 Regulates Obesity-Induced Inflammation Through Regulation of Adipose Tissue Macrophage Polarization , 2013, Diabetes.
[47] Geoffrey S. Tobias,et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium , 2013, Cancer Causes & Control.
[48] D. Mathis. Immunological goings-on in visceral adipose tissue. , 2013, Cell metabolism.
[49] Z. Tabka,et al. Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women , 2015, Pediatric Rheumatology.
[50] Yongmei Yin,et al. Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk , 2013, PloS one.
[51] W. Frankel,et al. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. , 2013, Cancer research.
[52] J. Wojta,et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue , 2013, International Journal of Obesity.
[53] P. Hojman,et al. The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.
[54] R. Locksley,et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.
[55] Stephen T. C. Wong,et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. , 2013, Cell metabolism.
[56] Reiko Nishihara,et al. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. , 2013, Cancer research.
[57] M. VanSaun. Molecular Pathways Molecular Pathways : Adiponectin and Leptin Signaling in Cancer , 2013 .
[58] J. Manson,et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.
[59] R. Flavell,et al. JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation , 2013, Science.
[60] A. Tessitore,et al. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages , 2012, BioMed research international.
[61] R. Kittler,et al. Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer , 2012, Proceedings of the National Academy of Sciences.
[62] H. El‐Serag,et al. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[63] P. Scherer,et al. Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.
[64] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[65] F. Carbone,et al. Immunological functions of leptin and adiponectin. , 2012, Biochimie.
[66] Mary T. Brinkoetter,et al. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice , 2012, Gut.
[67] N. Jhala,et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.
[68] D. Bar-Sagi,et al. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. , 2012, Cancer cell.
[69] M. Lotze,et al. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway , 2012, Autophagy.
[70] L. Fartoux,et al. HCC and NASH: how strong is the clinical demonstration? , 2012, Clinics and research in hepatology and gastroenterology.
[71] C. Mantzoros,et al. The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.
[72] C. Benoist,et al. PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells , 2012, Nature.
[73] A. Chumanevich,et al. Adiponectin deficiency: role in chronic inflammation induced colon cancer. , 2012, Biochimica et biophysica acta.
[74] Shanchun Guo,et al. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. , 2012, Biochimica et biophysica acta.
[75] Douglas Hanahan,et al. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .
[76] B. Spiegelman,et al. Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.
[77] J. Drew. Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin , 2011, Proceedings of the Nutrition Society.
[78] V. Tutino,et al. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. , 2011, Anticancer research.
[79] C. la Vecchia,et al. Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. , 2011, Metabolism: clinical and experimental.
[80] E. Riboli,et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort , 2011, Diabetologia.
[81] G. Coukos,et al. The parallel lives of angiogenesis and immunosuppression: cancer and other tales , 2011, Nature Reviews Immunology.
[82] H. El-Mesallamy,et al. The interplay of YKL-40 and leptin in type 2 diabetic obese patients. , 2011, Diabetes research and clinical practice.
[83] Michael Karin,et al. Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.
[84] J. Arthur,et al. Leptin up‐regulates pro‐inflammatory cytokines in discrete cells within mouse colon , 2011, Journal of cellular physiology.
[85] D. Leroith,et al. Minireview: IGF, Insulin, and Cancer. , 2011, Endocrinology.
[86] J. Samet,et al. Total cholesterol and cancer risk in a large prospective study in Korea. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[87] R. Locksley,et al. Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.
[88] Yuan Yuan Wang,et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. , 2011, Cancer research.
[89] K. Takeda,et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis , 2011, Gut.
[90] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[91] Vilmundur Gudnason,et al. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .
[92] M. Karin,et al. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.
[93] M. Kolonin,et al. Influence of BMI on Level of Circulating Progenitor Cells , 2011, Obesity.
[94] M. Suárez-Fariñas,et al. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. , 2011, The American journal of clinical nutrition.
[95] M. Karin,et al. Role of TLR2‐dependent inflammation in metastatic progression , 2011, Annals of the New York Academy of Sciences.
[96] N. Zarghami,et al. The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients , 2011, Breast cancer : basic and clinical research.
[97] R. Locksley,et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.
[98] H. Tilg,et al. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.
[99] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[100] Yuichi Akasaki,et al. Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.
[101] J. Fenton,et al. Adipokine regulation of colon cancer: Adiponectin attenuates interleukin‐6‐induced colon carcinoma cell proliferation via STAT‐3 , 2010, Molecular carcinogenesis.
[102] M. Coory,et al. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.
[103] M. Inoue,et al. Insulin resistance and cancer: Epidemiological evidence , 2010, Cancer science.
[104] F. Greenway,et al. Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.
[105] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[106] Wei Zheng,et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.
[107] R. Odze,et al. Aga Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease Learning Objectives Are Patients with Ibd at Increased Risk for Developing Crc? Uc , 2022 .
[108] Jun Hee Lee,et al. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.
[109] D. Nomura,et al. Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.
[110] C. Picó,et al. Gene Expression Patterns in Visceral and Subcutaneous Adipose Depots in Rats are Linked to Their Morphologic Features , 2009, Cellular Physiology and Biochemistry.
[111] Isao Usui,et al. Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.
[112] S. Lipkin,et al. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. , 2009, Cancer research.
[113] T. Kadowaki,et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.
[114] Christophe Benoist,et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.
[115] H. Pitt,et al. Obesity potentiates the growth and dissemination of pancreatic cancer. , 2009, Surgery.
[116] C. Bouchard,et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. , 2009, The Lancet. Oncology.
[117] F. Balkwill. Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.
[118] E. Calle,et al. Cancer Incidence and Mortality After Gastric Bypass Surgery , 2009, Obesity.
[119] A. Walch,et al. Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion , 2009, Proceedings of the National Academy of Sciences.
[120] M. Vasson,et al. IL‐1 family in breast cancer: Potential interplay with leptin and other adipocytokines , 2009, FEBS letters.
[121] B. Aggarwal,et al. Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.
[122] N. Zeps,et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] E. Giovannucci,et al. Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer , 2008, Clinical Cancer Research.
[124] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[125] B. Aggarwal,et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.
[126] H. Reber,et al. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.
[127] Vidya Subramanian,et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. , 2008, Cell metabolism.
[128] M. Czech,et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.
[129] M. Karin,et al. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.
[130] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[131] J. Leips,et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.
[132] D. Tuveson,et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.
[133] Charles F Burant,et al. The rapidly expanding family of adipokines. , 2007, Cell metabolism.
[134] Frank Brombacher,et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.
[135] Zheng Zhang,et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.
[136] P. Rothwell,et al. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.
[137] R. Rosenfeld. Work , 2007, Sometime Kin.
[138] H. Alexander,et al. Journal of Translational Medicine Interleukin-1 and Cancer Progression: the Emerging Role of Interleukin-1 Receptor Antagonist as a Novel Therapeutic Agent in Cancer Treatment , 2022 .
[139] A. Renehan,et al. Obesity and cancer risk: the role of the insulin–IGF axis , 2006, Trends in Endocrinology & Metabolism.
[140] Herbert Tilg,et al. Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.
[141] M. Karin,et al. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[142] J. Johansen. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. , 2006, Danish medical bulletin.
[143] G. Kundu,et al. Osteopontin: role in cell signaling and cancer progression. , 2006, Trends in cell biology.
[144] D. Albanes,et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.
[145] Michael Karin,et al. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.
[146] C. Stove,et al. Roles for neuregulins in human cancer , 2005, Clinical & Experimental Metastasis.
[147] R. Stubbs,et al. Loss of Insulin Resistance after Roux-en-Y Gastric Bypass Surgery: a Time Course Study , 2005, Obesity surgery.
[148] A. Hevener,et al. IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.
[149] J. Samet,et al. Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.
[150] K. Clément,et al. The FASEB Journal • Research Communication Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects , 2022 .
[151] M. Singer,et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults , 2004, International Journal of Obesity.
[152] E. Bleecker,et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. , 2004, The American journal of clinical nutrition.
[153] B. Sipos,et al. Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β , 2004, Cancer Research.
[154] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[155] Jayadev Raju,et al. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. , 2003, Cancer research.
[156] D. Mcfadden,et al. Differential effects of leptin on cancer in vitro. , 2003, The Journal of surgical research.
[157] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[158] R. Schwabe,et al. c‐Jun‐N‐terminal kinase drives cyclin D1 expression and proliferation during liver regeneration , 2003, Hepatology.
[159] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[160] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[161] S. Deventer,et al. Leptin is a growth factor for colonic epithelial cells. , 2001, Gastroenterology.
[162] P. Schauer,et al. Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity , 2000, Annals of surgery.
[163] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[164] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[165] B Rosner,et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. , 1999, American journal of epidemiology.
[166] Gretchen A. Stevens,et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.
[167] C. Mantzoros,et al. Leptin in nonalcoholic fatty liver disease: a narrative review. , 2015, Metabolism: clinical and experimental.
[168] R. Dalle Grave,et al. Increased Risk of Colorectal Cancer After Obesity Surgery. , 2015, Annals of surgery.
[169] L. Hebbard,et al. Multifaceted roles of adiponectin in cancer. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[170] K. Cho,et al. Imaging white adipose tissue with confocal microscopy. , 2014, Methods in enzymology.
[171] Christopher J. Lyon,et al. Inflammasomes and Obesity , 2013 .
[172] G. Musso,et al. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. , 2013, Progress in lipid research.
[173] Sagar Ghosh,et al. An IL-6 link between obesity and cancer. , 2013, Frontiers in bioscience.
[174] M. Karin,et al. Hepatocyte IKK β / NF-κ B inhibits tumor promotion and progression by preventing oxidative stress driven STAT 3 activation , 2010 .
[175] S. Yakar,et al. Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. , 2010, Cancer research.
[176] M. Ruth. Normalization of obesity-associated insulin resistance through immunotherapy , 2010 .
[177] P. Siiteri. Adipose tissue as a source of hormones. , 1987, The American journal of clinical nutrition.